Moxonidine
Overview
Moxonidine is antihypertensive agent acts on imidazoline sub-type 1 receptors to the brain medula. Used alone or in combination therapy to reduce mild to moderate blood pressure. May cause dry mouth, headache, nausea and insomnia.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
BCG Vaccine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 200 ug | 200 (200) | 24 hourly | | Initially. |
| 400 ug | 400 (400) | As recommended. | | As a single or in 2 divided doses . |
| 600 ug | 600 (600) | As recommended. | | After further 3 weeks |
Paedriatic Dosage (20kg)
|
| | | | Not recommended for this age group |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
BCG Vaccine
Back to top
Previous Drug Generic - Next Drug Generic